SE0201940D0 - New combination II - Google Patents
New combination IIInfo
- Publication number
- SE0201940D0 SE0201940D0 SE0201940A SE0201940A SE0201940D0 SE 0201940 D0 SE0201940 D0 SE 0201940D0 SE 0201940 A SE0201940 A SE 0201940A SE 0201940 A SE0201940 A SE 0201940A SE 0201940 D0 SE0201940 D0 SE 0201940D0
- Authority
- SE
- Sweden
- Prior art keywords
- new combination
- relates
- disease
- reflux
- thrive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/04—Sulfinic acids; Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
ARP030102095A AR040203A1 (es) | 2002-06-20 | 2003-06-11 | Combinacion de un inhibidor del reflujo y una imidazopiridina para el tratamiento de la gerd |
PCT/SE2003/001008 WO2004000856A1 (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
AU2003237739A AU2003237739A1 (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
TW092116257A TW200403059A (en) | 2002-06-20 | 2003-06-16 | Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0201940D0 true SE0201940D0 (sv) | 2002-06-20 |
Family
ID=20288298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0201940A SE0201940D0 (sv) | 2002-06-20 | 2002-06-20 | New combination II |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR040203A1 (sv) |
AU (1) | AU2003237739A1 (sv) |
SE (1) | SE0201940D0 (sv) |
TW (1) | TW200403059A (sv) |
WO (1) | WO2004000856A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP2006003708A0 (en) | 2000-05-26 | 2006-08-31 | Idenix Cayman Ltd | Methods and compositions for treating flavivirusesand pestiviruses |
RS20050868A (en) * | 2003-05-27 | 2007-08-03 | Altana Pharma Ag., | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
WO2005077345A1 (en) * | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
WO2006050472A2 (en) | 2004-11-03 | 2006-05-11 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids |
US7566738B2 (en) | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
US7585996B2 (en) | 2006-09-15 | 2009-09-08 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
WO2011092290A1 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
US8835444B2 (en) | 2010-02-02 | 2014-09-16 | Novartis Ag | Cyclohexyl amide derivatives as CRF receptor antagonists |
US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
SG11201405810UA (en) | 2012-05-03 | 2014-11-27 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
SE9801526D0 (sv) * | 1998-04-29 | 1998-04-29 | Astra Ab | New compounds |
SE9904507D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
-
2002
- 2002-06-20 SE SE0201940A patent/SE0201940D0/sv unknown
-
2003
- 2003-06-11 AR ARP030102095A patent/AR040203A1/es not_active Application Discontinuation
- 2003-06-16 TW TW092116257A patent/TW200403059A/zh unknown
- 2003-06-16 AU AU2003237739A patent/AU2003237739A1/en not_active Abandoned
- 2003-06-16 WO PCT/SE2003/001008 patent/WO2004000856A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003237739A1 (en) | 2004-01-06 |
WO2004000856A1 (en) | 2003-12-31 |
AR040203A1 (es) | 2005-03-16 |
TW200403059A (en) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0201940D0 (sv) | New combination II | |
ATE408601T1 (de) | Fredericamycin-derivate | |
ATE344029T1 (de) | Behandlung von typ ii diabetes mit dipeptidyl- peptidase-iv-hemmern | |
ATE461217T1 (de) | Glp-1-verbindungen | |
CY1109240T1 (el) | Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο | |
ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
LTC1562603I2 (lt) | Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui | |
NO20052591L (no) | Pyridopyrolizin og pyridoindolizinderivater | |
CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
RS52942B (en) | TREATMENT OF TYPE 2 DIABETES BY THE COMBINATION OF DPIV IHIBITORS AND METFORMIN OR THIAZOLIDINDION | |
NO20052512L (no) | Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander | |
DK1543011T3 (da) | Thienopyrrolyl- og furanopyrrolylforbindelser og deres anvendelse som histamin H4-receptorligander | |
NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
SE0301882D0 (sv) | New use I | |
SE0301888D0 (sv) | New use VII | |
NO20070608L (no) | Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast | |
DK1973539T3 (da) | Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression | |
MX2007002470A (es) | Fenilaminotiazoles sustituidos y su uso. | |
PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
BRPI0410467A (pt) | composições e métodos para tratamento de sìndrome respiratória aguda severa (sars) | |
NO20043115L (no) | Substituerte diketopiperaziner som oksytocin antagonister | |
CY1110369T1 (el) | Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη | |
DE50310038D1 (de) | Hemmstoffe der urokinase, ihre herstellung und verwendung | |
HRP20050439B1 (en) | New use of dextran sulfate |